Julio Triana is currently Head of Commercial Operations Region International for Bayer’s Pharmaceuticals Division
The Supervisory Board of Bayer AG has appointed Julio Triana to Bayer’s Board of Management effective April 1, 2024. He will become President of the Consumer Health Division effective May 1, 2024, and succeed Heiko Schipper, who has asked the Supervisory Board to bring forward the end date of his contract to pursue a career opportunity outside of Bayer. Schipper will leave the company effective April 30, 2024.
Julio Triana is currently Head of Commercial Operations Region International for Bayer’s Pharmaceuticals Division, a member of the Division’s Executive Committee as well as the Senior Bayer Representative Japan and President of Bayer Holding, Ltd. Japan. Triana is a very seasoned executive with a dynamic 30-year career in the global healthcare industry. He joined Bayer in 2002 and has held roles of increasing responsibility in Finance, Strategy, Business Development and most recently Commercial Operations, among others. Triana holds an MBA from Universidad Antonio de Nebrija (Madrid, Spain) as well as a Bachelor of Science in Biology from the University of Houston (Houston, Texas, USA). He has comprehensive experience in leading and transforming large organizations across multiple functions and in different cultural contexts with a strong track record of successful market expansions, sustainable revenue growth and orchestrating complex integrations.
